retatrutide triple agonist glp-1 gip glucagon phase 2 obesity Retatrutide, a GIP, and receptor agonist, for people with type diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, 2 trial conducted in the USA Dual and Triple Gut Peptide

Diabetes 51(9):27572763 Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP

In the case of diabetes, that means regulating blood sugar by boosting insulin and slowing down digestion

In the LIVE trial, liraglutide had no meaningful impact on SBP or left ventricular function in HFrEF but increased heart rate by approximately 7 beats per minute

The Wegovy injection pen has a needle already built-in to the device, while the Ozempic pen comes with needles to be attached

This hormone does several important things simultaneously

GLP-1 medications do not change which bacteria you have, but they change the environment those bacteria operate in